Devnandini Rastogi
Psychiatry · Saint Louis, MONPI 1710903935
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $214,521 of the $260,807 with a category attached, or 82.3%. 6 manufacturers reported payments, led by Johnson & Johnson at 34.8% of the total. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $736.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$91K
- Otsuka America Pharmaceutical, Inc.$83K
- E.r. Squibb & Sons, L.L.C.$50K
- Alkermes, Inc.$30K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$7K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$232
What the payments were for
- Consulting fees$17,6227%
- Speaking & faculty fees$214,52182%
- Travel & lodging$20,5558%
- Food & beverage$8,1053%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 123 | $90,813 |
| Otsuka America Pharmaceutical, Inc. | 119 | $82,878 |
| E.r. Squibb & Sons, L.L.C. | 57 | $50,443 |
| Alkermes, Inc. | 32 | $29,520 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $6,921 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $232 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$117,589
- INVEGA SUSTENNA$88,496
- INVEGA TRINZA$87,558
- ABILIFY MAINTENA$80,743
- ABILIFY ASIMTUFII$44,756
- COBENFY$36,293
- ARISTADA INITIO$29,397
- CAPLYTA$6,536
- REXULTI$887
- INVEGA$498
How this compares
$260,807 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Saint Louis
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- George GrossbergSaint Louis$501K
- Christopher LoyndSaint Louis$265K
- Michael StotlerSaint Louis$250K
- James ChoSaint Louis$118K
- Steven HarveySaint Louis$90K
- Kevin BlackSaint Louis$77K
- Eric LenzeSaint Louis$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.